Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Exp Neurol. 2017 Jun 3;295:162–175. doi: 10.1016/j.expneurol.2017.06.005

Figure 1. Basal ACh measured in vivo is elevated in DYT1 mouse model.

Figure 1

(A) TorAΔE /+ mice show siginificantly increased basal extracellular ACh levels; *p< 0.05. (B) Dose-related ACh increase in both TorA+/+ and TorAΔE /+ animals with neostigmine bromide in aCSF; *p< 0.05 ANOVA with Tukey’s post-hoc test for individual concentrations. (C) Diagram of probe placements in striatum (CPu).